Purpose
to evaluate direct and indirect impact of Pneumococcal conjugate vaccine (PCV13) in South Africa
Grantee
Division
Global Health
Date
APRIL 2018
Region served
AFRICA
Committed amount
$1,893,025
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
58
Grantee location
Parktown, Gauteng, South Africa
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.